Product Information

DOXAZOSIN MESYLATE 4 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0805 per EA under NDC 59762139007. Its NADAC has been published 51 times since Dec 3, 2025.

FDA first approved this application on Nov 2, 1990. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the doxazosin mesylate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

DOXAZOSIN MESYLATE 4 MG TAB

doxazosin mesylate
$0.0805per EA
Low Outlier

Strength

4 mg/1

NDC

59762139007

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DOXAZOSIN MESYLATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA019668

FDA Approved

11/2/1990

TE Code

AB

On Market Since

9/24/2025

Pharmacological Classes

Adrenergic alpha-Antagonists
alpha-Adrenergic Blocker

Price Statistics

The NADAC for DOXAZOSIN MESYLATE 4 MG TAB has been published 51 times since Dec 3, 2025, and over the history we have for it it has declined 11.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0805 per EA
All-time high$0.0975 (Apr 15, 2026)
All-time low$0.0802 (Oct 21, 2026)
52-week high$0.0975
52-week low$0.0802
Median price$0.0927
Average price$0.0910
Largest weekly change-5.4% (Jun 17, 2026)
Weeks tracked51
Tracking sinceDec 3, 2025

Price History

1W

+0.4%

1M

-3.5%

3M

-6.0%

6M

-16.4%

1Y

N/A

3Y

N/A

5Y

N/A

All

-11.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DOXAZOSIN MESYLATE 4 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DOXAZOSIN MESYLATE 4 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.0805 per EA (NDC 59762139007), effective Nov 18, 2026.

How has the price of DOXAZOSIN MESYLATE 4 MG TAB changed over time?

Over the history we have for it, the NADAC for DOXAZOSIN MESYLATE 4 MG TAB has declined 11.7%. It has been tracked across 51 weekly CMS publications since Dec 3, 2025.

What are the highest and lowest recorded NADAC prices for DOXAZOSIN MESYLATE 4 MG TAB?

Since Dec 3, 2025, the NADAC for DOXAZOSIN MESYLATE 4 MG TAB has ranged from a low of $0.0802 (Oct 21, 2026) to a high of $0.0975 (Apr 15, 2026), with a median of $0.0927 per EA.

Are there cheaper alternatives to DOXAZOSIN MESYLATE 4 MG TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOXAZOSIN MESYLATE 4 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures DOXAZOSIN MESYLATE 4 MG TAB?

DOXAZOSIN MESYLATE 4 MG TAB (NDC 59762139007) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.